Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)Evaluation of Non-cytotoxic Suramin as a Chemosensitizer in Non-small Cell Lung Cancer
Phase 2
Terminated
- Conditions
- Non-small Cell Lung Cancer
- First Posted Date
- 2009-12-24
- Last Posted Date
- 2015-05-21
- Lead Sponsor
- Optimum Therapeutics, LLC
- Target Recruit Count
- 14
- Registration Number
- NCT01038752
- Locations
- 🇺🇸
John H Stroger Jr Hospital of Cook County, Chicago, Illinois, United States
🇺🇸Virginia Commonwealth University Massey Cancer Center, Richmond, Virginia, United States
News
No news found